GN Store Nord A/S logo

GN - GN Store Nord A/S News Story

DKK490.1 15.0  3.2%

Last Trade - 3:59pm

Sector
Healthcare
Size
Large Cap
Market Cap £6.88bn
Enterprise Value £7.38bn
Revenue £1.69bn
Position in Universe 107th / 1832

BUZZ-Hearing devices: Demant's Oticon MORE the new benchmark - CS

Fri 16th April, 2021 7:18am
**  Given patient satisfaction, price-to-value and quality
metrics, Demant's  DEMANT.CO  product Oticon MORE appears to
have become the benchmark, says Credit Suisse based on the
hearing device survey
    ** CS largely expects global market in the hearing devices
sector to normalise and expand by about 24%, bringing it 2%
above 2019 levels 
    ** Overall, industry contacts suggest hearing device market
has improved in 2021, evidenced by materially higher sales in
the VA channel in the US in March, says CS
    ** "In Europe, we have seen solid trends since the start of
the year in key markets such as Germany and France, despite more
extensive government measures to control the pandemic compared
with the US", it adds
    ** CS upgrades Demant to "neutral" from "underperform" in
light of strong survey results for the new product Oticon MORE 
    ** On the other hand it cuts GN Store  GN.CO  to "neutral"
from "outperform" saying survey results on the ReSound ONE are
not encouraging, and GN Hearing could miss management guidance
for 2021 FX adj. sales growth and lose substantial market share
    ** CS reiterates "outperform" on Sonova  SOON.S  as the
Phonak Paradise remains a solid product, also supported by
strong Veteran Affairs (VA) market momentum and market share
data

 ((joanna.wodzicka@tr.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.